MINI REVIEW
Published on 29 Sep 2026
GAN-enhanced digital twins for biomarker-guided cancer immunotherapy and adoptive cell therapy: a mini review
doi 10.3389/fmed.2026.1894314
- 745 views
Articles
MINI REVIEW
Published on 11 Sep 2026
Nurse-coordinated biomarker and symptom monitoring for immune checkpoint inhibitor toxicity
doi 10.3389/fmed.2026.1949715
- 456 views
MINI REVIEW
Published on 09 Sep 2026
The economic value of mismatch repair–guided immunotherapy in endometrial cancer: companion testing and patient selection
doi 10.3389/fmed.2026.1951624
- 402 views
MINI REVIEW
Published on 09 Sep 2026
ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer
doi 10.3389/fmed.2026.1942673
- 504 views
MINI REVIEW
Published on 02 Sep 2026
Toward nursing-integrated biomarker surveillance for immune-related adverse events during immune checkpoint inhibitor therapy
doi 10.3389/fmed.2026.1943642
- 626 views
MINI REVIEW
Published on 13 Aug 2026
Biomarker-driven immunotherapy and adoptive cell therapy in recurrent pancreatic ductal adenocarcinoma
doi 10.3389/fmed.2026.1900701
- 741 views
- 1 citation
ORIGINAL RESEARCH
Published on 10 Aug 2026
Biomarker-integrated machine learning models for predicting treatment-related bowel dysfunction after rectal cancer surgery: a multicenter development and external validation study
doi 10.3389/fmed.2026.1907311
- 760 views
MINI REVIEW
Published on 22 Jul 2026
Targeting molecular residual disease and immune escape in colorectal cancer recurrence: biomarker-guided immunotherapy and cell therapies
doi 10.3389/fmed.2026.1906283
- 928 views
PERSPECTIVE
Published on 30 Jun 2026
Out“FOX”ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy
doi 10.3389/fmed.2026.1883380
- 1,389 views
MINI REVIEW
Accepted on 28 Sep 2026
CT Imaging Biomarkers After Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer: From Response Assessment to Surgical Decision-Making
- 102 views
MINI REVIEW
Accepted on 30 Sep 2026
Biomarker-Guided Immunotherapy in Osteosarcoma: From Immune Microenvironment Profiling to Patient Stratification and Combination Strategies
MINI REVIEW
Accepted on 02 Oct 2026
Artificial Intelligence–Enabled Nursing Surveillance for Pediatric Cancer Immunotherapy: Integrating Biomarkers, Patient-Reported Outcomes, and Long-Term Toxicity Management
- 120 views
